Items tagged with Access
Experts call for collective action to end TB in the Western Pacific (post)
Denarau, Fiji, Nov 23, 2016 – While there has been remarkable progress in the fight against tuberculosis (TB) in the Western Pacific region over the past two decades, the disease remains a major public health problem and a renewed effort is required to end the epidemic, said public health experts who gathered this week in Fiji for a regional TB meeting.
UN Secretary-General urges action on High-Level Panel report on medicines access (post)
United Nations Secretary-General Ban Ki-moon issued a message praising the “milestone” report of a High-Level Panel on access to medicines he set up a year ago to address the continuing problem of medicines prices being too high for many in the world to afford, and the lack of access to quality medicines for many. In his message, he called on governments to review the report and its recommendations, and to chart a way forward to address the problem of lack of access to medicines and health technologies.
Pressure builds on WHO to show leadership on access to medicines (post)
Frustrated at the lack of commitment by the World Health Organization (WHO) on intellectual property and access to medicines, civil society organizations are making their views known. With a decision on the shortlist for the new WHO Director General imminent, HIV treatment and health activists are calling for strong leadership on issues related to innovation, intellectual property and access to health commodities, including medicines.
RNTBCP Nagaland launches 99 DOTS and IPT (post)
Kohima, December 12 (MExN): The Revised National TB Control Programme (RNTBCP) Nagaland has become one of the states in India to launch the 99 DOTS (Daily Anti TB Treatment) for TB and HIV co-infected patients and IPT (Isoniazid Preventative Therapy) for PLHIV on December 9 at NHAK Conference hall.
Shortage of TB doctors in Myanmar leading to patient backlogs (post)
Head doctors at hospitals around Myanmar are calling for more resources to be dedicated to the fight against tuberculosis, as a current shortfall in medical officers has left patients waiting on treatment.
Charity demands Seoul allow TB medication shipment to N. Korea (post)
The nonprofit Eugene Bell Foundation on Thursday (December 22) called on the South Korean Ministry of Unification (MoU) to allow a shipment of multidrug-resistant tuberculosis (MDR-TB) medication to arrive in North Korea as it had promised in August.
Hospital against access to life-saving drug for TB patient as case reaches Delhi High Court (post)
Officials from the National Institute of Tuberculosis and Respiratory Diseases on Monday (January 9) told the Delhi High Court that providing bedaquiline, a life-saving drug, to an 18-year-old woman suffering from a drug-resistant form of TB would fail to treat her. They warned that it may cause the drug-resistant bacteria to spread in her body.
Medicines Patent Pool’s next steps in TB: stewardship report (post)
In the context of its mandate expansion into tuberculosis, the Medicines Patent Pool (MPP) was asked by its funder, UNITAID, to conduct a study to examine how MPP licences could contribute to addressing some of the stewardship challenges for new drugs for tuberculosis, specifically for multidrug-resistant TB. The report seeks to inform the Foundation’s approach to negotiating licences and sub-licences for the manufacturing of TB compounds. It acknowledges the twin public health goals of ensuring broad availability of new therapies while promoting their proper use to counter further resistance.
Africa: Dying from lack of medicines (post)
Approximately 1.6 million Africans died of malaria, tuberculosis and HIV-related illnesses in 2015. These diseases can be prevented or treated with timely access to appropriate and affordable medicines, vaccines and other health services. But less than 2% of drugs consumed in Africa are produced on the continent, meaning that many sick patients do not have access to locally produced drugs and may not afford to buy the imported ones.
Delhi hospital agrees to give life-saving drug to TB patient after initial denial (post)
The National Institute of Tuberculosis and Respiratory Diseases on Wednesday (January 18) agreed to administer life-saving drug Bedaquiline to an 18-year-old woman from Patna who suffers from drug-resistant form of TB. “The drug has to be given in combination with other drugs, but doctors at the institute cannot give it to her without first conducting a drug-susceptibility test,” said Saket Sikri, the lawyer representing the institute at the Delhi High Court.
Page 26 of 83 · Total posts: 0
←First 25 26 27 Last→